A number of PIM inhibitors have been investigated in leukemia cells, [36–39], however, few have been investigated in CLL, thus we evaluated the effect of inhibition of PIM kinases alone using AZD1208. This evidence concerns the gene PIM1 and B-cell chronic lymphocytic leukemia.